Search

Four months after the Brexit vote, the landscape is as uncertain for UK companies as on 24 June. The needs of life sciences must be understood and the sector given a bigger say in exit negotiations, says former health minister, Stephen Dorrell

The EU-funded Innovative Medicines Initiative is making advances in harnessing health records at scale, unlocking the power of data to tackle hard-to-beat diseases

Amsterdam-based knowledge institutes and the municipality of Amsterdam will invest heavily in making scientific knowledge and technology available for societal and economic applications

European Commission has put forward rules on how R&D could be supported through an ambitious new tax system. In an example given by the Commission, a company that spends €30 million on R&D could deduct €42.5 million from its taxable income

The UK vote to leave the EU is symbolic of a more widespread anti-globalisation sentiment that could hamper international collaboration and limit the supply of foreign talent. This could weaken Europe’s university-industry clusters as a whole

To realise the great promise of 5G technologies, Europe needs to step up its game in terms of policy, investment and education

EU today launches public survey on R&D programme, to run until January

The European Commission launches the Bohemia Study, a foresight exercise aiming to ensure the next EU research programme is equal to the challenges of the 2020s

Its parent organisation had a damning review from the European Court of Auditors in April, but Willem Jonker, CEO of the European Institute of Innovation and Technology’s digital cluster tells Science|Business the foundations are in place for future growth

Research commissioner Carlos Moedas reaffirms his commitment to free-to-view access to scientific research funded by the public purse

Karolinksa spin out Dilaforette changes name to Modus Therapeutics and announces intention to conduct an Initial Public Offering

Rotterdam, Stockholm, Munich among 10 digital hubs with a unique European flavour, according to new Science|Business report

KU Leuven’s Centre for Drug Design and Discovery closes €60 million fund to turn academic research into new medicines

Director-general for research and innovation, Robert-Jan Smits outlines plans for Framework Programme 9. A foresight study is underway and a public consultation opens next month, Smits tells a Science|Business meeting

Now two years old, Brussels’ talent-spotter is slowly turning into one of Europe’s most recognised start-up engines, with bets on a wide range of intriguing ideas

A think-tank set up by the Austrian government calls for simpler rules, more robust evaluation, greater participation from non-EU researchers - and a guarantee that the FP9 budget will not be raided to fund other schemes